A medspa books a full Saturday: Botox, filler, a handful of new patients starting a weight loss program. Every chart has a Good Faith Exam on file, signed and dated. On paper, the medspa is covered.
Then a state board inquiry — or an insurer's audit, or a new medical director doing a chart review — asks a harder question: who actually performed that exam, and what did they know about this specific patient before signing off? Sometimes the honest answer is uncomfortable. The exam happened. The exam was not much of an exam.
The problem comes from treating the Good Faith Exam as a form to complete rather than what it actually is.
What a Good Faith Exam is for
Done right, a Good Faith Exam means a qualified clinician has actually evaluated a patient — their history, their goals, their contraindications — before treatment starts, with a real clinical relationship behind whatever gets prescribed or performed afterward. It's meant to answer "should this patient get this treatment," not just "did someone sign a form."
That distinction is the whole post.
Mistake one: the exam is a formality, not a review
One version of this: a new patient fills out an intake form, a supervising clinician skims it and signs, and the patient never has a real conversation with anyone before their first appointment. The form exists. The judgment behind it doesn't.
A medspa adding injectables, weight loss, or peptide therapy on top of an already busy calendar needs Good Faith Exams to keep pace with bookings, and the fastest way to keep pace is to make the exam thinner. The exam gets faster right when the treatment list — and the contraindications a real review would catch — is getting longer.
Mistake two: no one behind the exam for the next visit
Medspas that treat a Good Faith Exam as a one-time credential a patient carries forward, then hand ongoing follow-up to front-desk workflow, have quietly removed the clinician from every decision after the first one — no one stays accountable for what happens with that patient after the day they signed the intake.
That gap is invisible until something goes wrong — a patient with a new medication, or a contraindication that only becomes relevant later. The exam did its job on day one. Nothing was built to catch what happens after.
Mistake three: coverage that doesn't match how the medspa actually runs
Multi-location medspas run into a version of this that's more structural: a different arrangement, a different clinician, a different standard of review at each site. One location's exams are thorough; another's are rushed because the covering clinician is stretched across three practices that day. Documentation looks consistent because the same form is used everywhere. The exam behind the form isn't.
None of this is a compliance conclusion — that's worth a real answer from counsel or a compliance-minded medical director rather than a guess. The practical issue is structural: a Good Faith Exam is only as good as the clinician doing it and the oversight standing behind it, and per-visit, per-location coverage makes that standard hard to hold constant.
What it costs
The cost of getting this wrong isn't abstract. It shows up as exposure if a patient is harmed by something a real exam would have caught. And it shows up in the ordinary version: a medical director who's reviewing charts they signed months ago and can't stand behind what they said, because they were never really behind it in the first place.
None of that is solved by better paperwork. It's solved by making the exam and the oversight around it real, consistently, at whatever volume the medspa runs.
Where to start
If you're not sure where your own exams stand, the fastest check is simple: pick five recent charts and ask whether the exam on file reflects an actual review of that patient, or a signature on a form that would look the same for anyone. If the answer makes you uneasy, that's the place to start — before it's a board inquiry asking the same question.
The harder question to sit with: if a regulator or a new medical director pulled those same five charts tomorrow, could you point to who did the exam, what they actually reviewed, and who's accountable for the patient's next visit — or would the paper trail be the only answer you have?
Some programs include compounded or off-label therapies. Treatment appropriateness is determined by a licensed provider after individual evaluation. Build.MD does not provide medical care directly; all clinical services are provided by Access Plus Medical or its affiliated providers.
Editorial standards: how these posts are researched, sourced, and reviewed.
← All posts